+86(1360)2568149 info@phcoker.com

Raw Phenylpiracetam powder (77472-70-9)

Phenylpiracetam (4 fenilpiratsetam “Phenotropil”)  is a powerful synthetic stimulant nootropic. Phenylpiracetam powder has……..

Status: In Mass Production
Unit: 25kg/Drum
Capacity: 1350kg/month


Raw Phenylpiracetam powder (77472-70-9) video


Raw Phenylpiracetam powder (77472-70-9) Description

Raw Phenylpiracetam powder is a powerful racetam nootropic,It’s a potent stimulant that may also improve mood, memory, cognition, and even athletic performance.

Raw Phenylpiracetam powder’s chemical structure is the same as piracetam, with an additional phenyl group attached. The phenyl group increases Raw Phenylpiracetam powder’s ability to dissolve in fats, oils, and lipids, which in turn may enhance its absorption within the body.This property may explain why Raw Phenylpiracetam powder is more potent than piracetam and how it crosses the blood-brain barrier more readily and efficiently.

Raw Phenylpiracetam powder acts as an ampakine, increasing levels of the excitatory neurotransmitter glutamate by stimulating AMPA receptors. This action is associated with improved cognitive function and may play a significant role in Raw Phenylpiracetam powder’s ability to enhance memory, focus, and overall cognition.

Raw Phenylpiracetam powder (77472-70-9) Specifications

Product Name Raw Phenylpiracetam powder
Chemical Name 4-Phenyl-2-pyrrolidone-1-acetamide; 2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide; 4-Raw Phenylpiracetam powder
Brand Name Phenotropil; Carphedon
Drug Class Nootropic(GABA derivative)
CAS Number 77472-70-9
Molecular Formula C12H14N2O2
Molecular Weight 218.25g/mol
Monoisotopic Mass 218.24
Melting Point  126-128oC
Freezing Point No data for available
Biological Half-Life 2–3 hours
Color White powder
Solubility  In PBS, pH 7.2, is approximately 10 mg/ml.
Storage Temperature  Store at -20°C
Application Improve mood, memory, cognition, and even athletic performance.


Raw Phenylpiracetam powder (77472-70-9)

Phenylpiracetam is a drug belonging to the group of neuro protective drugs. In North America and other parts of the world, phenylpiracetam powder is widely used off-label as a nootropic, believed by many to enhance memory, focus, productivity, and physical stamina.

Phenylpiracetam is a modified version of piracetam developed at the Russian Academy of Sciences in 1983. It was created as a treatment for the prolonged stress experienced by cosmonauts on extended space missions.‍

Though human research on phenylpiracetam powder is limited to a small number of Russian studies, it has been shown to help restore neurological functions and daily living activities to post-stroke patients,‍ and improve depression, anxiety, and cognitive function in patients with organic brain lesions.‍

Phenylpiracetam powder (77472-70-9) Mechanism of Action

In the brain, phenylpiracetam has several mechanisms of action, most of which involve stimulating the production of various neurotransmitters.

It acts as an ampakine, increasing levels of the excitatory neurotransmitter glutamate by stimulating AMPA receptors. This action is associated with improved cognitive function‍ and may play a significant role in phenylpiracetam’s ability to enhance memory, focus, and overall cognition.

Animal studies showed that phenylpiracetam powder also increases extracellular dopamine levels, both by activating the dopaminergic system and by acting as a dopamine reuptake inhibitor.‍ Dopamine is an important neurotransmitter that is associated with reward, motivation, memory, attention and the regulation of emotions and body movements. Increased dopamine levels are believed to be responsible, at least in part, for phenylpiracetam’s positive effects on motivation, mood, and focus.

Dopamine is also a direct precursor of the stimulatory neurotransmitter norepinephrine, which increases heart rate, blood pressure, and the levels of fat and sugar in the blood. These effects are thought to be related to phenylpiracetam’s energy and stamina boosting capability.

Like other racetam-type nootropics, phenylpiracetam also increases production of acetylcholine, sometimes referred to as “the learning neurotransmitter” because it is so closely associated with all aspects of cognition. The brain uses choline to produce acetylcholine and may quickly deplete its stores when taking racetams, which is why supplemental choline is generally suggested to be taken with phenylpiracetam.

Benefits of Phenylpiracetam powder (77472-70-9)

  • Memory and Cognitive Enhancement
  • Energy Booster
  • Anxiety Reducer and Antidepressant

Recommended Phenylpiracetam powder (77472-70-9) Dosage

The phenylpiracetam dosage varies depending on the needs and studies, the recommend dosage range from 200mg -600mg

  • Dosages 200mg (100mg twice daily) up to 600mg (200mg thrice daily)
  • Over a period of 1 month.

It is sold in both tablet and powder form, generally of 100 mg each.

Side effects of Phenylpiracetam powder (77472-70-9)

Like other nootropics in the racetam class, there are few reported side effects from supplementing phenylpiracetam at the recommended dosages.

Phenylpiracetam can cause headaches because it boosts the use of acetylcholine in your brain. Choline supplements like Alpha GPC or CDP-Choline can help you avoid this side effect.

Some users report unpleasant effects the day after taking phenylpiracetam, including irritability and brain fog.‍

Others say that taking high doses of phenylpiracetam continuously over a prolonged period can result in difficulty sleeping, depression, and emotional instability.‍



This Material is Sold For Research Use Only. Terms of Sale Apply. Not for Human Consumption, nor Medical, Veterinary, or Household Uses.


References & product citations

Nootropics Phenylpiracetam: Benefits+Danger+Stacks丨Phcoker



  1. Zhilyuk, V. I., Levykh, A. E., & Mamchur, V. I. (2014). A Study of the Mechanisms for Antiaggregant Activity of Pyrrolidone Derivatives in Rats with Chronic Hyperglycemia. Bulletin of experimental biology and medicine156(6), 799.
  2. Rekis, T., Be̅rziņš, A., Orola, L., Holczbauer, T., Actiņš, A., Seidel-Morgenstern, A., & Lorenz, H. (2017). Single enantiomer’s urge to crystallize in centrosymmetric space groups: solid solutions of phenylpiracetam. Crystal Growth & Design17(3), 1411-1418.
  3. Blank, R. H. (2016). Introduction to Cognitive Enhancement. In Cognitive Enhancement: Social and Public Policy Issues(pp. 1-41). Palgrave Macmillan, London.
  4. Szulc, B. R. (2015). Synthesis and discovery of the putative cognitive enhancer BRS-015: effect on glutamatergic transmission and synaptic plasticity(Doctoral dissertation, UCL (University College London).